Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.

Solanki AA, LeMieux MH, Chiu BC, Mahmood U, Hasan Y, Koshy M.

PLoS One. 2013 Sep 18;8(9):e75336. doi: 10.1371/journal.pone.0075336. eCollection 2013.

2.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
3.

Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.

LeMieux MH, Solanki AA, Mahmood U, Chmura SJ, Koshy M.

Cancer Med. 2015 Apr;4(4):513-8. doi: 10.1002/cam4.405. Epub 2015 Jan 26.

4.

Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.

Wirth A, Yuen K, Barton M, Roos D, Gogna K, Pratt G, Macleod C, Bydder S, Morgan G, Christie D.

Cancer. 2005 Sep 15;104(6):1221-9.

5.

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.

Vlachaki MT, Hagemeister FB, Fuller LM, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):593-9.

PMID:
9231684
6.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.

J Clin Oncol. 2010 Jan 1;28(1):136-41. doi: 10.1200/JCO.2009.24.0945. Epub 2009 Nov 23.

PMID:
19933914
7.

Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.

Gerber NK, Atoria CL, Elkin EB, Yahalom J.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):76-83. doi: 10.1016/j.ijrobp.2015.02.012. Epub 2015 Mar 14.

8.

Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.

Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, Magrini SM.

Tumori. 2005 Nov-Dec;91(6):456-62.

PMID:
16457141
9.

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4. Chinese.

PMID:
19102946
10.

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.

Ai Zheng. 2006 Aug;25(8):1013-8. Chinese.

PMID:
16965685
11.

High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.

van Grotel M, Lam KH, de Man R, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM.

Leuk Lymphoma. 2006 Aug;47(8):1504-10.

PMID:
16966260
12.

Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.

Shah AB, Hudson MM, Poquette CA, Luo X, Wilimas JA, Kun LE.

Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):867-77.

PMID:
10386644
13.

Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.

Hallemeier CL, Pisansky TM, Davis BJ, Choo R.

Urol Oncol. 2013 Nov;31(8):1832-8. doi: 10.1016/j.urolonc.2012.03.010. Epub 2012 Apr 25.

PMID:
22537538
14.

Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.

Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):126-32. doi: 10.1016/j.ijrobp.2015.09.017. Epub 2015 Sep 25.

PMID:
26547384
15.

Is combined modality therapy necessary for advanced Hodgkin's disease?

Mendenhall NP, Bennett CJ Jr, Lynch JW Jr.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):583-92.

PMID:
9231683
16.

Subdiaphragmatic Hodgkin's disease: the University of Florida experience.

Hull MC, Mendenhall NP, Colgan ME.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):161-6.

PMID:
11777634
17.
18.

BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.

Rüffer JU, Ballova V, Glossmann J, Sieber M, Franklin J, Nogova L, Diehl V, Josting A; German Hodgkin Study Group.

Leuk Lymphoma. 2005 Nov;46(11):1561-7.

PMID:
16236610
19.

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.

Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO; Nebraska Lymphoma Study Group.

Leuk Lymphoma. 2003 Nov;44(11):1903-10.

PMID:
14738141
20.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Liao Z, Ha CS, Fuller LM, Hagemeister FB, Cabanillas F, Tucker SL, Hess MA, Cox JD.

Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1047-56.

PMID:
9719114

Supplemental Content

Support Center